AIMEE RODRIGUEZ, APRN, FNP-C
Family Nurse Practitioner · CORONA DEL MAR, CA
Individual Active NPI 1649898743
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 498 | 359,252 | $13,081,014 | $6,151,157 | $4,902,185 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0174 | Injection, lecanemab-irmb, 1 mg | 93,461 | $1 | $1 |
| J1306 | Injection, inclisiran, 1 mg | 50,269 | $12 | $10 |
| J3262 | Injection, tocilizumab, 1 mg | 37,557 | $6 | $5 |
| J3032 | Injection, eptinezumab-jjmr, 1 mg | 21,300 | $18 | $14 |
| J0897 | Injection, denosumab, 1 mg | 16,921 | $26 | $21 |
| J2182 | Injection, mepolizumab, 1 mg | 11,300 | $30 | $24 |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 10,080 | $11 | $9 |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 9,870 | $11 | $9 |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 7,400 | $43 | $34 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 5,404 | $31 | $25 |
| 96372 | Injection of drug or substance under skin or into muscle | 845 | $13 | $11 |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 653 | $61 | $48 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Family Nurse Practitioner | 363LF0000X | ✓ | 95014811 | CA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- No
Other Family Nurse Practitioner providers in California
- NPI 1306541511
- NPI 1992539761
- NPI 1497308936
- NPI 1497512453
- NPI 1215212717
- NPI 1255140836
- NPI 1437027125
- NPI 1841029659
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.